Dual-Hormone, Artificial Pancreas with Insulin and Pramlintide Significantly Improves Glucose Levels, Compared to Insulin-Only Artificial Pancreas

Print More
(PRNewsFoto/American Diabetes Association)

ORLANDO, Fla., June 23, 2018 /PRNewswire-USNewswire/ -- A dual-hormone, artificial pancreas1 delivering rapid insulin and the drug pramlintide improved glucose control and reduced glucose variability in adults with type 1

Comments are closed.